DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $28.40 Average Price Target from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) has been assigned a consensus rating of “Hold” from the twelve analysts that are currently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $27.91.

Several equities analysts have recently weighed in on the stock. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Morgan Stanley decreased their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Mizuho began coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective on the stock.

Check Out Our Latest Research Report on XRAY

Institutional Trading of DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in XRAY. Blue Trust Inc. raised its stake in shares of DENTSPLY SIRONA by 1,062.5% in the second quarter. Blue Trust Inc. now owns 5,638 shares of the medical instruments supplier’s stock valued at $140,000 after acquiring an additional 5,153 shares during the period. Raymond James & Associates boosted its position in shares of DENTSPLY SIRONA by 15.1% during the second quarter. Raymond James & Associates now owns 1,157,506 shares of the medical instruments supplier’s stock valued at $28,833,000 after buying an additional 152,099 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of DENTSPLY SIRONA by 377.2% during the second quarter. Louisiana State Employees Retirement System now owns 58,700 shares of the medical instruments supplier’s stock valued at $1,462,000 after buying an additional 46,400 shares during the last quarter. Retirement Systems of Alabama lifted its stake in shares of DENTSPLY SIRONA by 448.0% during the 2nd quarter. Retirement Systems of Alabama now owns 256,267 shares of the medical instruments supplier’s stock worth $6,384,000 after acquiring an additional 209,506 shares during the last quarter. Finally, LRI Investments LLC grew its position in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.2 %

Shares of DENTSPLY SIRONA stock opened at $18.70 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a market cap of $3.72 billion, a price-to-earnings ratio of -9.03, a price-to-earnings-growth ratio of 1.93 and a beta of 0.97. The company’s 50 day moving average is $20.72 and its 200 day moving average is $23.85.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s revenue for the quarter was up .4% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. Research analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.42%. DENTSPLY SIRONA’s payout ratio is -30.92%.

About DENTSPLY SIRONA

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.